Does Better Care At Hospitals Come with a Security Risk?

 

Hospitals are living, breathing and fluid environments that see hundreds if not thousands of visitors each day. Today, the devices that keep these buildings running are more connected than ever, which allows for an exceptional level of care but brings tremendous risks at the same time.

Cybersecurity in hospitals is a complex issue that has left the medical world particularly vulnerable to hackers and digital adversaries who seek personal health records, bank accounts and more.

Associate Professor of Computer Science and Engineering at New York University’s Tandon School of Engineering, Justin Cappos, has spent years analyzing cybersecurity and notes that hospitals are particularly susceptible to cyber-attacks. He points out that a lack of uniformity among devices in hospitals contributes to the difficulty of securing the entire building and its data, among other issues.

“It’s not the case that you can just go and get a completely integrated, whole hospital-wide solution that has a unified security posture and has everything set up in a very easy way,” Cappos said.

The information that can be extracted from hospitals by hackers is extremely sensitive and valuable, but accountability on the security of this content is something still being addressed by hospitals, technology manufacturers and the federal government, but to date no sweeping changes have been made.

To see how cybersecurity is changing industries across the world, visit our healthcare and software & technology industry pages.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More